Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Researchers identify compounds from Aspergillus that may be effective against SARS-CoV-2

Researchers identify compounds from Aspergillus that may be effective against SARS-CoV-2

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

Development of a novel surface plasmon resonance-based assay to determine kinetics of SARS-CoV-2 spike – human ACE2 interaction

Development of a novel surface plasmon resonance-based assay to determine kinetics of SARS-CoV-2 spike – human ACE2 interaction

Study reveals serum proteomic signatures of long COVID patients

Study reveals serum proteomic signatures of long COVID patients

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

Dogs can detect SARS-CoV-2 from an individual's sweat

Dogs can detect SARS-CoV-2 from an individual's sweat

Bayesian viral allele selection for SARS-CoV-2 genomic surveillance

Bayesian viral allele selection for SARS-CoV-2 genomic surveillance

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

T-cell responses after COVID-19 and vaccinations

T-cell responses after COVID-19 and vaccinations

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

SARS-CoV-2-related caregiver mortality and orphanhood among children

SARS-CoV-2-related caregiver mortality and orphanhood among children

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Researchers identify cellular serpins as host factors that restrict SARS-CoV-2 infection

Researchers identify cellular serpins as host factors that restrict SARS-CoV-2 infection

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Evaluating mental health of adults with neurodevelopmental disorders during COVID-19 pandemic

Evaluating mental health of adults with neurodevelopmental disorders during COVID-19 pandemic

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.